Samsung Biologics Co.,Ltd.

Research Samsung Biologics Co.,Ltd. (207940) on Bullrun: market cap KRW 68.79T. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker207940
ExchangeKS
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 68.79T
Financial periodQ1 2026
RevenueKRW 1.26T
Net incomeKRW 469.25B
Free cash flowKRW 676.16B
Gross margin54.1%

Valuation Snapshot

latest market cap is KRW 68.79T.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	KRW 4.26T	KRW 1.78T	KRW 772.73B	54.6%	n/a	KRW 148.85B	KRW 927.09B	KRW 7.45T

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-28	KRW 68.79T	n/a	n/a	n/a

About Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

HLB Co., Ltd. (028300) Celltrion, Inc. (068270) ALTEOGEN Inc. (196170) Tubacex (0KD1) Neovacs S.A. (0LW0) TME PHARM.CONF.IPO EO 1- (0N6A) Selvaag Bolig ASA (0Q92) Camurus AB (0RD1) Adalta Ltd (1AD) ONCOARENDI THERAP ZY-01 (1B1) WUXI BIOLOGICS-00000083 (1FW2) Adicet Bio Inc (1IJ)

Frequently asked questions

What is Samsung Biologics Co.,Ltd.'s market cap?

Samsung Biologics Co.,Ltd.'s market capitalization is KRW 68.79T.